Bendamustine and Rituximab
(BEN-duh-MUS-teen and rih-TUK-sih-mab)
Bendeka™, Treanda™, Belrapzo™ and Rituxan™, Ruxience™, Truxima™
“BR” is used to treat:
• Chronic lymphocytic leukemia (CLL), which starts with certain white blood cells in the bone marrow and then goes into the blood.
• Slow-growing non-Hodgkin lymphomas (NHL), which starts with certain white blood cells in the lymph system. NHL include diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), MALT lymphoma, mantle cell lymphoma, nodal and splenic marginal zone lymphoma, Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
"BR" regimen is mostly commonly used for CLL and NHL but may be used for other treatments.
Our Medication Sheet
This sheet is available to download as an Adobe PDF.